NCT06818799Completed
Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer
Evaluation of Thulium Laser Endoscopic En-bloc Resection Versus Conventional Trans-urethral En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer
Source: ClinicalTrials.gov · Last updated 12 Feb 2025
Brief summary (registry, in English)
The goal of this clinical trial is to know if thulium laser works to treat non-muscle invasive bladder cancer "NMIBC" efficiently in comparison to classical trans-urethral resection "TURBT". It will also learn about the safety of this technique. The main questions it aims to answer are: Does thulium laser lower the incidence of recurrence to participants with non- muscle invasive bladder cancer? What complications do participants have when using this technique? Investigators will compare thulium laser en-bloc resection to a classical trans-urethral en-bloc resection of bladder tumor Participants will: Do thulium laser en-bloc resection or trans-urethral en-bloc resection And will be classified to risk group according to European association of urology guidelines and followed up accordingly.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 5 Feb 2025
- Start date
- 13 Aug 2023
- Primary completion date
- 15 Nov 2024
- Lead sponsor
- Helwan University
- Diseases
- Bladder cancer
- NCT number
- NCT06818799
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 13 Aug 2023 to the primary completion date, 15 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received previous chemotherapy or radiotherapy
Other illness
- Other pathological types of bladder cancer
Other
- Large bladder mass \> 3 cm measured by CT urography
- Recurrent tumor
- Patients that confirmed post operative histopathology with muscle-invasive bladder transitional cell carcinoma
Who the study is looking for
- Age : adults and older adults
- patients with bladder transitional cell carcinoma
- Imaging examinations showed small bladder mass \< 3 cm and the bladder muscle has not been affected, no lymph node metastasis or distant metastasis;
- Primary tumor
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Helwan University Coordinator of this site? Confirm its status | Helwan | Egypt | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.